Catherine Coste

Insider Reports History

Entity
Individual
Location
966 Ocho Rios Dr, Danville, California
Signature
/s/ Catherine Coste
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Coste:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOMERICA INC Director Common stock 43.8K $67.9K $1.55 Dec 13, 2023 Direct
MINERVA SURGICAL INC Director Common Stock 130K $26.5K $0.20 Jun 10, 2022 Direct
Renalytix plc Director Employee Stock Option (right to buy) 95K Nov 20, 2023 Direct
BIOMERICA INC Director Non-qualified stock option 75K Dec 13, 2023 Direct

Insider Reports Filed by Catherine Coste

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMRA BIOMERICA INC Dec 13, 2023 1 $0 4 Dec 14, 2023 Director
BMRA BIOMERICA INC Dec 7, 2023 1 $0 4 Dec 11, 2023 Director
RNLX Renalytix plc Nov 20, 2023 1 $0 4 Nov 22, 2023 Director
RNLX Renalytix plc Jul 6, 2023 1 $0 4 Jul 7, 2023 Director
RNLX Renalytix plc Jul 1, 2023 0 $0 3 Jul 3, 2023 Director
BMRA BIOMERICA INC Jan 26, 2023 1 $6.48K 4 Jan 30, 2023 Director, Audit Committee Chairperson
UTRS MINERVA SURGICAL INC Jun 10, 2022 1 $120K 4 Jun 14, 2022 Director
BMRA BIOMERICA INC Dec 9, 2021 1 $0 4 Dec 10, 2021 Director
UTRS MINERVA SURGICAL INC Oct 21, 2021 0 $0 3 Oct 21, 2021 Director